Clinical Trial Update: A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome [Phase 2]

View source ↗

Summary

A Phase II exploratory trial evaluating fucose supplementation for GLUT1 deficiency syndrome; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome

Drugs mentioned

• L-fucose (L-fucose)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Glut1 Deficiency, GLUT1DS1 | Phase 2 | Status: NOT_YET_RECRUITING